A previous study used a microarray dataset including 90 lung cancer specimens to analyze FOXD1 mRNA levels to find that abnormal FOXD1 mRNA was associated with the survival of NSCLC patients. This evidence concerns the gene FOXD1 and non-small cell lung carcinoma.